Results 191 to 200 of about 22,796,869 (307)

Mechanistic models of humoral kinetics following COVID-19 vaccination. [PDF]

open access: yesJ R Soc Interface
Stocks D   +4 more
europepmc   +2 more sources

Deep time evolution of the Latitudinal Diversity Gradient: Insights from mechanistic models. [PDF]

open access: yesPLoS One
Lorcery M   +5 more
europepmc   +1 more source

Biophysical and Mechanistic Models for Disease-Causing Protein Variants.

open access: yesTIBS -Trends in Biochemical Sciences. Regular ed, 2019
A. Stein   +3 more
semanticscholar   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Mechanistic models position ceritinib as a nuclear integrity disrupting therapy in pediatric liver tumors. [PDF]

open access: yesJ Exp Clin Cancer Res
Demir S   +13 more
europepmc   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

Rapid, interpretable data-driven models of neural dynamics using recurrent mechanistic models. [PDF]

open access: yesProc Natl Acad Sci U S A
Burghi TB   +5 more
europepmc   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy